Dabrafenib Mesylate and Emtricitabine, rilpivirine, and tenofovir
Determining the interaction of Dabrafenib Mesylate and Emtricitabine, rilpivirine, and tenofovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: emtricitabine / rilpivirine / tenofovir
Brand name: Complera, Odefsey
Synonyms: Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Dabrafenib Mesylate-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Dabrafenib Mesylate-Emtriva
- Dabrafenib Mesylate-Emtriva (Emtricitabine Capsules)
- Dabrafenib Mesylate-Emtriva (Emtricitabine Solution)
- Dabrafenib Mesylate-Emverm
- Emtricitabine, rilpivirine, and tenofovir-Dacarbazine
- Emtricitabine, rilpivirine, and tenofovir-Dacarbazine Intravenous, Injection
- Emtricitabine, rilpivirine, and tenofovir-Daclatasvir
- Emtricitabine, rilpivirine, and tenofovir-Daclatasvir Dihydrochloride
- Emtricitabine, rilpivirine, and tenofovir-Daclizumab
- Emtricitabine, rilpivirine, and tenofovir-Daclizumab Subcutaneous